Hospital-acquired thrombosis, caused by the formation of blood clots during hospitalization, is a major risk factor for the development of venous thromboembolic disease (VTE).

Up to 60% of cases of venous thromboembolic disease (VTE) occur during or within 90 days of hospitalization, making it the main cause of in-hospital deaths worldwide, but which could be prevented, says the professor of Vascular Surgery of the University of Thessaly, Miltiadis MatsagasPresident of the Institute for the Study of Thrombosis and Antithrombotic Education (IMETHA), on the occasion of World Thrombosis Day (October 13).

IMETHA, with the support of 18 scientific companies and the Ministry of Health, continues for the 11th year in a row to inform and raise awareness among doctors, health professionals and the public about thrombosis that can occur during hospitalization.

Patients who remain immobile due to bed rest or recovering from surgery, as well as those with blood vessel injuries, are at increased risk of thrombosis. Implementing VTE risk assessment protocols and taking preventive measures is key to reducing deaths caused by thrombosis, says Mr Matsagas.

Thrombosis, according to the President of IMETHA, is mainly responsible for the first three cardiovascular causes of death worldwide: acute heart attack, stroke and venous thromboembolic disease (VTE).

A very important and hopeful message of World Thrombosis Day is that thrombosis is preventable and treatable, emphasized Dimitris RichterVice-President and incoming President of IMETHA.

Prevention of nosocomial thrombosis is critical to patient protection. Physicians and nurses should assess each patient’s thromboembolic risk upon admission to the hospital. Preventive measures include promoting patient movement, using anticoagulant medications, and applying compression stockings to improve blood flow. With these measures, the risk of thrombosis can be significantly reduced and serious complications can be prevented.

Prevention, early diagnosis and treatment of thrombosis will lead to a reduction in deaths from thrombosis and a significant reduction in overall mortality rates, but will also improve quality of life worldwide, emphasizes Mr. Richter.